Bioceres Crop Solutions (NASDAQ:BIOX) is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets. Bioceres also delivers a suite of bioinputs under brands such as Rizotec and Naturity, combining natural microorganisms and plant-derived compounds to promote root development and protect against soil-borne pathogens. In addition, the company is expanding its digital agriculture capabilities through remote sensing, data analytics and precision application tools.
Headquartered in Argentina, Bioceres operates production and research facilities across Latin America, North America, Europe and Australia, with commercial offices and distribution partnerships in more than 20 countries. The company’s global footprint enables it to adapt formulations to regional agronomic practices and regulatory frameworks, supporting farmers in major row‐crop regions and emerging markets alike.
Bioceres Crop Solutions traces its origins to pioneering biotech ventures in Argentina during the 1990s and was spun off as a separate public entity in 2019, listing on the Nasdaq under the ticker BIOX in early 2020. The company is led by President and Chief Executive Officer Daniel A. Ponzinibbio, whose executive team oversees research, regulatory affairs, manufacturing and global commercial operations as part of a long-term innovation strategy.
